# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-25-021165
Filing Date
2025-03-06
Accepted
2025-03-06 16:02:05
Documents
122
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0230445-10k_orukathe.htm iXBRL | 10-K | 2354570
2 | DESCRIPTION OF SECURITIES | ea023044501ex4-1_orukathe.htm | EX-4.1 | 35667
3 | FORM OF PRE-FUNDED WARRANT, DATED AUGUST 29, 2024 | ea023044501ex4-3_orukathe.htm | EX-4.3 | 84585
4 | AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN ORUKA THERAPEUTI | ea023044501ex10-17_orukathe.htm | EX-10.17 | 64901
5 | AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN ORUKA THERAPEUTI | ea023044501ex10-18_orukathe.htm | EX-10.18 | 64180
6 | FORM OF INDEMNIFICATION AGREEMENT | ea023044501ex10-19_orukathe.htm | EX-10.19 | 60880
7 | NON-EMPLOYEE DIRECTORS COMPENSATION PROGRAM | ea023044501ex10-20_orukathe.htm | EX-10.20 | 6137
8 | IL-17 LICENSE AGREEMENT BY AND BETWEEN PARAGON THERAPEUTICS, INC. AND ORUKA THER | ea023044501ex10-29_orukathe.htm | EX-10.29 | 264577
9 | IL-23 LICENSE AGREEMENT BY AND BETWEEN PARAGON THERAPEUTICS, INC. AND ORUKA THER | ea023044501ex10-31_orukathe.htm | EX-10.31 | 266790
10 | CELL LINE LICENSE AGREEMENT BY AND BETWEEN WUXI BIOLOGICS IRELAND LIMITED AND OR | ea023044501ex10-32_orukathe.htm | EX-10.32 | 85539
11 | AMENDMENT NO. 1 TO THE CELL LINE LICENSE AGREEMENT BY AND BETWEEN WUXI BIOLOGICS | ea023044501ex10-33_orukathe.htm | EX-10.33 | 13150
12 | INSIDER TRADING POLICY | ea023044501ex19-1_orukathe.htm | EX-19.1 | 118955
13 | LIST OF SUBSIDIARIES OF THE REGISTRANT | ea023044501ex21-1_orukathe.htm | EX-21.1 | 1967
14 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ea023044501ex23-1_orukathe.htm | EX-23.1 | 1679
15 | CERTIFICATION | ea023044501ex31-1_orukathe.htm | EX-31.1 | 10131
16 | CERTIFICATION | ea023044501ex31-2_orukathe.htm | EX-31.2 | 9724
17 | CERTIFICATION | ea023044501ex32-1_orukathe.htm | EX-32.1 | 4597
18 | INCENTIVE COMPENSATION CLAWBACK POLICY | ea023044501ex97-1_orukathe.htm | EX-97.1 | 36056
24 | GRAPHIC | image_001.jpg | GRAPHIC | 55273
25 | GRAPHIC | image_002.jpg | GRAPHIC | 184389
26 | GRAPHIC | image_003.jpg | GRAPHIC | 147984
27 | GRAPHIC | image_003a.jpg | GRAPHIC | 70063
28 | GRAPHIC | image_004.jpg | GRAPHIC | 39573
29 | GRAPHIC | image_005.jpg | GRAPHIC | 46697
30 | GRAPHIC | image_006.jpg | GRAPHIC | 51283
31 | GRAPHIC | image_007.jpg | GRAPHIC | 58482
32 | GRAPHIC | ex10-17_001.jpg | GRAPHIC | 34126
33 | GRAPHIC | ex10-18_001.jpg | GRAPHIC | 35538
34 | GRAPHIC | ex19-1_001.jpg | GRAPHIC | 20082
35 | GRAPHIC | ex97-1_001.jpg | GRAPHIC | 20938
| Complete submission text file | 0001213900-25-021165.txt |  | 12618504

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
19 | XBRL SCHEMA FILE | orka-20241231.xsd | EX-101.SCH | 83439
20 | XBRL CALCULATION FILE | orka-20241231_cal.xml | EX-101.CAL | 45629
21 | XBRL DEFINITION FILE | orka-20241231_def.xml | EX-101.DEF | 395007
22 | XBRL LABEL FILE | orka-20241231_lab.xml | EX-101.LAB | 701513
23 | XBRL PRESENTATION FILE | orka-20241231_pre.xml | EX-101.PRE | 421239
124 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0230445-10k_orukathe_htm.xml | XML | 1077648

Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 25715110
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)